These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11576794)

  • 1. Enzymatic characterization of TEM-63, a TEM-type extended spectrum beta-lactamase expressed in three different genera of Enterobacteriaceae from South Africa.
    Hanson ND; Smith Moland E; Pitout JD
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):199-201. PubMed ID: 11576794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
    Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of bla(CTX-M-1)-group extended-spectrum beta-lactamase genes in Enterobacteriaceae isolates from Emilia-Romagna, Italy.
    Gagliotti C; Sarti M; Benini F; Cipolloni AP; Venturelli C; Sabia C; Gargiulo R; Moro ML
    J Med Microbiol; 2009 Oct; 58(Pt 10):1388-1389. PubMed ID: 19541784
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination and persistence of a plasmid-mediated TEM-3-like beta-lactamase, TEM-139, among Enterobacteriaceae in Bulgaria.
    Schneider I; Markovska R; Keuleyan E; Sredkova M; Rachkova K; Mitov I; Bauernfeind A
    Int J Antimicrob Agents; 2007 Jun; 29(6):710-4. PubMed ID: 17382521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cointegrate-like plasmid that facilitates dissemination by conjugation of the extended-spectrum β-lactamase CTX-M-17.
    Lin DL; Ramirez MS; Tran T; Tolmasky ME
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5191-2. PubMed ID: 23877684
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.
    Giani T; Antonelli A; Caltagirone M; Mauri C; Nicchi J; Arena F; Nucleo E; Bracco S; Pantosti A; ; Luzzaro F; Pagani L; Rossolini GM
    Euro Surveill; 2017 Aug; 22(31):. PubMed ID: 28797330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000).
    Navarro F; Perez-Trallero E; Marimon JM; Aliaga R; Gomariz M; Mirelis B
    J Antimicrob Chemother; 2001 Sep; 48(3):383-9. PubMed ID: 11533003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 13. TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.
    Corvec S; Beyrouthy R; Crémet L; Aubin GG; Robin F; Bonnet R; Reynaud A
    Antimicrob Agents Chemother; 2013 May; 57(5):2410-2. PubMed ID: 23478954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital.
    Hassan H; Abdalhamid B
    J Infect Dev Ctries; 2014 Mar; 8(3):282-8. PubMed ID: 24619257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CMY-type beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area.
    Decré D; Verdet C; Raskine L; Blanchard H; Burghoffer B; Philippon A; Sanson-Le-Pors MJ; Petit JC; Arlet G
    J Antimicrob Chemother; 2002 Nov; 50(5):681-8. PubMed ID: 12407124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
    Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
    Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance.
    Hansen DS; Schumacher H; Hansen F; Stegger M; Hertz FB; Schønning K; Justesen US; Frimodt-Møller N;
    Scand J Infect Dis; 2012 Mar; 44(3):174-81. PubMed ID: 22364227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Sabia C; Gargiulo R; Sarti M
    New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor-resistant beta-lactamases.
    Nicolas-Chanoine MH
    J Antimicrob Chemother; 1997 Jul; 40(1):1-3. PubMed ID: 9249197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.